Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Romania
  4. Bucharest Stock Exchange
  5. Antibiotice S.A.
  6. News
  7. Summary
    ATB   ROATBIACNOR9

ANTIBIOTICE S.A.

(ATB)
  Report
SummaryChartsNewsCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2020

02/26/2021 EST

Antibiotice S.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was RON 340.424 million compared to RON 389.710 million a year ago. Operating income was RON 33.700 million compared to RON 40.007 million a year ago. Net income was RON 25.063 million compared to RON 30.823 million a year ago.


ę S&P Capital IQ 2021
All news about ANTIBIOTICE S.A.
11/11Antibiotice S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
09/02ANTIBIOTICE S.A. : Ex-dividend day for final dividend
FA
07/26Antibiotice S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
05/12Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
02/26Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2020Antibiotice S.A. Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
2020ANTIBIOTICE SA : Ex-dividend day for final dividend
FA
2020Antibiotice S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
2019Antibiotice S.A. Reports Earnings Results for the Nine Months Ended September 30, 2019
CI
More news
Financials
Sales 2020 347 M 79,4 M 79,4 M
Net income 2020 26,4 M 6,04 M 6,04 M
Net Debt 2020 155 M 35,4 M 35,4 M
P/E ratio 2020 12,4x
Yield 2020 0,68%
Capitalization 383 M 87,6 M 87,5 M
EV / Sales 2019 1,32x
EV / Sales 2020 1,39x
Nbr of Employees 1 415
Free-Float 20,9%
Chart ANTIBIOTICE S.A.
Duration : Period :
Antibiotice S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 0,57 RON
Average target price 0,58 RON
Spread / Average Target 1,75%
Managers and Directors
Ioan Nani Vice Chairman & General Director
Paula-Luminita Coman Finance Director
Ionut Sebastian Iavor Chairman
Cornelia Moraru Director-Technical & Production
Mihaela Mosnegutu Medical Director
Sector and Competitors
1st jan.Capi. (M$)
ANTIBIOTICE S.A.17.28%88
JOHNSON & JOHNSON0.44%416 161
ROCHE HOLDING AG18.38%343 323
PFIZER, INC.48.55%306 912
NOVO NORDISK A/S66.91%247 444
ELI LILLY AND COMPANY47.55%225 859